BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Gross Profit

Gross Profit analysis for AEZS.

Quarterly Gross Profit

$819000.00
↓ 61.13% YoY

As of Jun 30, 2024

Annual Gross Profit (TTM)

$778888.00
↓ 90.83% YoY

Trailing 12 months ending Jun 30, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin